ONLINE DATABASE SEARCH - OI-LS-303-MEMO
1. 43948 OI-LS-303; PUBMED-OI-8/24/2004
Comparison of Ternary Complexes of Pneumocystis carinii and Wild-Type Human Dihydrofolate Reductase With a Novel Classical Antitumor Furo[2,3-d]pyrimidine Antifolate
Cody, V
Acta Crystallogr D Biol Crystallogr 97. 53(Pt 6): 638-649
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15299851&dopt=abstract
2. 43949 OI-LS-303; SCIFINDER-OI-8/17/2004
Effects of pesticides on sporulation of Cyclospora cayetanensis and viability of Cryptosporidium parvum
Sathyanarayanan, Lakshmi and Ortega, Ynes
Journal of Food Protection 2004. 67(5): 1044-1049
3. 43950 OI-LS-303; PUBMED-OI-8/24/2004
Inhibitors of 3C Cysteine Proteinases from Picornaviridae
Lall, MS, Jain, RP, and Vederas, JC
Curr Top Med Chem 2004. 4(12): 1239-53
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15320724&dopt=abstract
4. 43951 OI-LS-303; PUBMED-OI-8/24/2004
Antifungal pharmacokinetics and pharmacodynamics: understanding the implications for antifungal drug resistance
Andes, D
Drug Resist Updat 2004. 7(3): 185-194
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15296860&dopt=abstract
5. 43952 OI-LS-303; PUBMED-OI-8/24/2004
Effects of caspofungin (MK-0991) and anidulafungin (LY303366) on phagocytosis, oxidative burst and killing of Candida albicans by human phagocytes
Frank, U, Greiner, M, Engels, I, and Daschner, FD
Eur J Clin Microbiol Infect Dis 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15300456&dopt=abstract
6. 43953 OI-LS-303; PUBMED-OI-8/24/2004
Prp8 intein in fungal pathogens: target for potential antifungal drugs
Liu, XQ and Yang, J
FEBS Lett 2004. 572(1-3): 46-50
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15304322&dopt=abstract
7. 43954 OI-LS-303; PUBMED-OI-8/24/2004
Molecular characterisation of streptomycin-resistant Mycobacterium tuberculosis strains isolated in Poland
Brzostek, A, Sajduda, A, Sliwinski, T, Augustynowicz-Kopec, E, Jaworski, A, Zwolska, Z, and Dziadek, J
Int J Tuberc Lung Dis 2004. 8(8): 1032-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15305490&dopt=abstract
8. 43955 OI-LS-303; PUBMED-OI-8/24/2004
Antimycobacterial activity of synthetic pamamycins
Lefevre, P, Peirs, P, Braibant, M, Fauville-Dufaux, M, Vanhoof, R, Huygen, K, Wang, XM, Pogell, B, Wang, Y, Fischer, P, Metz, P, and Content, J
J Antimicrob Chemother 2004
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15317744&dopt=abstract
9. 43956 OI-LS-303; PUBMED-OI-8/24/2004
Interactions of 5-deazapteridine Derivatives with Mycobacterium tuberculosis and with Human Dihydrofolate Reductases
Da Cunha, EF, De Castro, Ramalho T, Bicca, De Alencastro R, and Maia, ER
J Biomol Struct Dyn 2004. 22(2): 119-130
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15317473&dopt=abstract
10. 43957 OI-LS-303; SCIFINDER-OI-8/17/2004
Antimicrobial activity of some thiadiazolyl- and triazolylbenzimidazoles
Kus, Canan, Ayhan-Kilcigil, Guelguen, and Altanlar, Nurten
Ankara Universitesi Eczacilik Fakultesi Dergisi 2004. 33(1): 1-6
11. 43958 OI-LS-303; PUBMED-OI-8/24/2004
The in vitro model of tissue cyst formation in Toxoplasma gondii
McHugh, TD, Holliman, RE, and Butcher, PD
Parasitol Today 94. 10(7): 281-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15275448&dopt=abstract
12. 43959 OI-LS-303; PUBMED-OI-8/24/2004
Substrate-induced asymmetry and channel closure revealed by the apoenzyme structure of Mycobacterium tuberculosis phosphopantetheine adenylyltransferase
Morris, VK and Izard, T
Protein Sci 2004. 13(9): 2547-52
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15322293&dopt=abstract
13. 43960 OI-LS-303; SCIFINDER-OI-8/17/2004
The antimicrobial activity of extracts of the lichen Cladonia foliacea and its (-)-usnic acid, atranorin, and fumarprotocetraric acid constituents
Yilmaz, Meral, Tuerk, Aysen Oezdemir, Tay, Turgay, and Kivanc, Merih
Zeitschrift fuer Naturforschung, C: Journal of Biosciences 2004. 59(3/4): 249-254
14. 43961 OI-LS-303; SCIFINDER-OI-8/17/2004
Antimicrobial activities of heparin-binding peptides
Andersson, Emma, Rydengard, Victoria, Sonesson, Andreas, Moergelin, Matthias, Bjoerck, Lars, and Schmidtchen, Artur
European Journal of Biochemistry 2004. 271(6): 1219-1226
15. 43962 OI-LS-303; WOS-OI-8/15/2004
Hindered nucleoside analogs as antiflaviviridae agents
Manfredini, S, Angusti, A, Veronese, AC, Durini, E, Vertuani, S, Nalin, F, Solaroli, N, Pricl, S, Ferrone, M, Mura, M, Piano, MA, Poddesu, B, Cadeddu, A, La, Colla P, and Loddo, R
PURE APPL CHEM 2004. 76(5): 1007-1015
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222693700014
16. 43963 OI-LS-303; SCIFINDER-OI-8/17/2004
Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted 6,7-difluoro-3-methylquinoxaline 1,4-dioxides
Carta, Antonio, Loriga, Mario, Paglietti, Giuseppe, Mattana, Antonella, Fiori, Pier Luigi, Mollicotti, Paola, Sechi, Leonardo, and Zanetti, Stefania
European Journal of Medicinal Chemistry 2004. 39(2): 195-203
17. 43964 OI-LS-303; SCIFINDER-OI-8/17/2004
Preparation of pyridyl triazinamines as microbiocides ((Ciba Specialty Chemicals Holding Inc., Switz.)
Hoelzl, Werner, Eichacker, Gabriele, and Preuss, Andrea
PATENT: WO 2004013124 A1; ISSUE DATE: 20040212
APPLICATION: 2003; PP: 34 pp.
18. 43965 OI-LS-303; WOS-OI-8/15/2004
Synthesis and antiviral evaluation of some novel tricyclic pyrazolo[3,4-b]indole nucleosides
Williams, JD, Drach, JC, and Townsend, LB
NUCLEOS NUCLEOT NUCL 2004. 23(5): 805-812
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222641300007
19. 43966 OI-LS-303; SCIFINDER-OI-8/17/2004
Antimicrobial efficacy of L-carnitine
Olgun, A, Kisa, O, Yildiran, ST, Tezcan, S, Akman, S, and Erbil, MK
Annals of Microbiology (Milano, Italy) 2004. 54(1): 95-101
20. 43967 OI-LS-303; WOS-OI-8/15/2004
Managing a portfolio of interdependent new product candidates in the pharmaceutical industry
Blau, GE, Pekny, JF, Varma, VA, and Bunch, PR
J PROD INNOVAT MANAG 2004. 21(4): 227-245
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222662900001
21. 43968 OI-LS-303; SCIFINDER-OI-8/17/2004
Combinations for the treatment of fungal infections ((Combinatorx Incorporated, USA)
Johansen, Lisa M, Serbedzija, George N, Auspitz, Benjamin A, Zimmermann, Grant R, Keith, Curtis, Nichols, James M, and Gaw, Debra A
PATENT: WO 2004002430 A2; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 69 pp.
22. 43969 OI-LS-303; WOS-OI-8/15/2004
Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis-like mechanism and survives in a compartment that differs from that with extracellular phenotype
Bermudez, LE, Petrofsky, M, and Sangari, F
CELL BIOL INT 2004. 28(5): 411-419
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222627500010
23. 43970 OI-LS-303; SCIFINDER-OI-8/17/2004
Design, Synthesis, and Biological Evaluation of 2,4-Diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as Dihydrofolate Reductase Inhibitors
Gangjee, Aleem, Lin, Xin, and Queener, Sherry F
Journal of Medicinal Chemistry 2004. 47(14): 3689-3692
24. 43971 OI-LS-303; WOS-OI-8/15/2004
Reporter substrates for assessing the activity of the hepatitis C virus NS3-4A serine protease in living cells
Pacini, L, Bartholomew, L, Vitelli, A, and Migliaccio, G
ANAL BIOCHEM 2004. 331(1): 46-59
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222697200006
25. 43972 OI-LS-303; SCIFINDER-OI-8/17/2004
Anti-microbial agents, diagnostic reagents, and vaccines based on unique Apicomplexan parasite components ((USA))
Mcleod, Rima LW, Roberts, Craig W, Roberts, Fiona, Johnson, Jennifer J, and Mets, Laurens
PATENT: US 6699654 B1; ISSUE DATE: 20040302
APPLICATION: 98-37795; PP: 81 pp.
26. 43973 OI-LS-303; WOS-OI-8/23/2004
Purification and characterization of Mycobacterium tuberculosis KatG, KatG(S315T), and Mycobacterium bovis KatG(R463L)
Wengenack, NL, Lane, BD, Hill, PJ, Uhl, JR, Lukat-Rodgers, GS, Hall, L, Roberts, GD, Cockerill, FR, Brennan, PJ, Rodgers, KR, Belisle, JT, and Rusnak, F
PROTEIN EXPRES PURIF 2004. 36(2): 232-243
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222863100010
27. 43974 OI-LS-303; SCIFINDER-OI-8/17/2004
Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice
Nakanaga, Kazue, Saito, Hajime, Ishi, Norihisa, and Goto, Masamichi
Kekkaku 2004. 79(5): 333-339
28. 43975 OI-LS-303; WOS-OI-8/23/2004
Proteome study of macrophage infected with Mycobacterium tuberculosis isoniazid resistant strain
Liu, LR, Yue, J, and Wang, HH
PROG BIOCHEM BIOPHYS 2004. 31(4): 361-367
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222848800014
29. 43976 OI-LS-303; SCIFINDER-OI-8/17/2004
Role for malonyl coenzyme A:acyl carrier protein transacylase (MCAT) in the growth-inhibitory effect of the calmodulin antagonist trifluoperazine in Mycobacterium bovis BCG
Sinha, Indrajit and Dick, Thomas
Journal of Antimicrobial Chemotherapy 2004. 53(6): 1072-1075
30. 43977 OI-LS-303; WOS-OI-8/23/2004
Imidazole analogues of fluoxetine, a novel class of anti-candida agents
Silvestri, R, Artico, M, La Regina, G, Di, Pasquali A, De Martino, G, D'Auria, FD, Nencioni, L, and Palamara, AT
J MED CHEM 2004. 47(16): 3924-3926
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222856800004
31. 43978 OI-LS-303; WOS-OI-8/23/2004
US firm licenses Cuban drug candidates
Anon
CHEM ENG NEWS 2004. 82(29): 10
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222813700023
32. 43979 OI-LS-303; SCIFINDER-OI-8/17/2004
Induction of Mycobacterium avium growth restriction and inhibition of phagosome-endosome interactions during macrophage activation and apoptosis induction by picolinic acid plus IfNg
Pais, Teresa F and Appelberg, Rui
Microbiology (Reading, United Kingdom) 2004. 150(5): 1507-1518
33. 43980 OI-LS-303; WOS-OI-8/23/2004
Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1
Vaitilingam, B, Nayyar, A, Palde, PB, Monga, V, Jain, R, Kaur, S, and Singh, PP
BIOORGAN MED CHEM 2004. 12(15): 4179-4188
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222886700023
34. 43981 OI-LS-303; SCIFINDER-OI-8/17/2004
Effects of gamma interferon, interleukin-10, and transforming growth factor b on the survival of Mycobacterium avium subsp. paratuberculosis in monocyte-derived macrophages from naturally infected cattle
Khalifeh, MS and Stabel, JR
Infection and Immunity 2004. 72(4): 1974-1982
35. 43982 OI-LS-303; WOS-OI-8/23/2004
Novel imidazo[1,2-c]pyrimidine base-modified nucleosides: synthesis and antiviral evaluation
Kifli, N, De Clercq, E, Balzarini, J, and Simons, C
BIOORGAN MED CHEM 2004. 12(15): 4245-4252
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222886700029
36. 43983 OI-LS-303; WOS-OI-8/23/2004
Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid
Michaelis, M, Kohler, N, Reinisch, A, Eikel, D, Gravemann, U, Doerr, HW, Nau, H, and Cinatl, J
BIOCHEM PHARMACOL 2004. 68(3): 531-538
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222881600014
37. 43984 OI-LS-303; SCIFINDER-OI-8/17/2004
Establishment of Mycobacterium avium subsp. paratuberculosis infection in the intestine of ruminants
Sigurethardottir, Olof G, Valheim, Mette, and Press, Charles McL
Advanced Drug Delivery Reviews 2004. 56(6): 819-834
38. 43985 OI-LS-303; SCIFINDER-OI-8/17/2004
Synthesis of Aldehydo-sugar Derivatives of Pyrazoloquinoline as Inhibitors of Herpes Simplex Virus Type 1 Replication
Bekhit, Adnan A, El-Sayed, Ola A, Aboul-Enein, Hassan Y, Siddiqui, Yunus M, and Al-Ahdal, Mohammed N
Journal of Enzyme Inhibition and Medicinal Chemistry 2004. 19(1): 33-38
39. 43986 OI-LS-303; SCIFINDER-OI-8/17/2004
Preparation of 3-(benzothiadiazin-3-yl)quinolines as HCV anti-infectives ((Smithkline Beecham Corporation, USA)
Chai, Deping, Duffy, Kevin J, Fitch, Duke M, Shaw, Antony N, Tedesco, Rosanna, Wiggall, Kenneth J, and Zimmerman, Michael N
PATENT: WO 2004052313 A2; ISSUE DATE: 20040624
APPLICATION: 2003; PP: 88 pp.
40. 43987 OI-LS-303; SCIFINDER-OI-8/17/2004
Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: Implications for the treatment of hepatitis C
Whitby, Kevin, Taylor, Debra, Patel, Dipa, Ahmed, Parvin, and Tyms, AStanley
Antiviral Chemistry & Chemotherapy 2004. 15(3): 141-151
41. 43988 OI-LS-303; SCIFINDER-OI-8/17/2004
The effects of a herbal medicine (Mao-to) in patients with chronic hepatitis C after injection of IFN-b
Kainuma, M, Sakai, S, Sekiya, N, Mantani, N, Ogata, N, Shimada, Y, and Terasawa, K
Phytomedicine 2004. 11(1): 5-10